2023
DOI: 10.3389/fimmu.2023.1118637
|View full text |Cite
|
Sign up to set email alerts
|

Neurotransmitters: promising immune modulators in the tumor microenvironment

Abstract: The tumor microenvironment (TME) is modified by its cellular or acellular components throughout the whole period of tumor development. The dynamic modulation can reprogram tumor initiation, growth, invasion, metastasis, and response to therapies. Hence, the focus of cancer research and intervention has gradually shifted to TME components and their interactions. Accumulated evidence indicates neural and immune factors play a distinct role in modulating TME synergistically. Among the complicated interactions, ne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 197 publications
0
3
0
Order By: Relevance
“…intermedia . Notably, GABA is an important inhibitory neurotransmitter in the body, and emerging data suggest that neurotransmitters can affect immune cells in the TME to regulate tumor progression [ 25 , 26 ]. Recent studies have confirmed that GABA and GABAB receptors, as potential tumor suppressors, have clear antitumor activity against liver cancer, pancreatic cancer, bile duct cancer, and colorectal cancer [ 25 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…intermedia . Notably, GABA is an important inhibitory neurotransmitter in the body, and emerging data suggest that neurotransmitters can affect immune cells in the TME to regulate tumor progression [ 25 , 26 ]. Recent studies have confirmed that GABA and GABAB receptors, as potential tumor suppressors, have clear antitumor activity against liver cancer, pancreatic cancer, bile duct cancer, and colorectal cancer [ 25 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…The authors found that this manipulation led to the accelerated growth of murine breast cancers. This sustained release of NE within tumor-influenced immune checkpoint proteins, such as PD-1, PD-L1, and FOXP3, is known to greatly inhibit the body’s antitumor immune actions [ 80 ]. Sympathetic denervation abrogated the oncogenic effect.…”
Section: Neural Regulation Of the Immune Systemmentioning
confidence: 99%
“…Neurotransmitters/neuropeptides such as ACh, GABA, serotonin (5-HT), NE, NPY, and neurotensin, which can be produced by tumor cells and immune cells inside the TLT, might affect cancer progression/metastasis through multiple signaling pathways (149,150). Neurotransmitters/neuropeptides and cytokines/chemokines that regulate tumor cell migration might provide an effective pharmacological approach for inhibiting cancer invasion/metastasis (151)(152)(153).…”
Section: Innervation Of Tltsmentioning
confidence: 99%